Patents by Inventor Shyam Sunder

Shyam Sunder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6288109
    Abstract: The invention relates to a novel 2H-1-pyran-2-ones of general formula (I), wherein R1 represents an alkyl radical with 2-5 C atoms, a cycloakyl radical with 4-6 C atoms, a cycloalkyl radical with 4-8 C atoms or an alkoxy alkyl radical with a total of 3-5 C atoms and R2 represents a 2-(3, 4-methylene dioxyphenyl) radical or a 2-phenyl ethenyl radical substituted with R3, R4 and R5 in positions 3, 4 and 5, whereby independently from each other R3 and R5 represent methoxy or ethoxy and R4 is a straight chain or branched alkoxy radical with 1-5 C atoms, an alkenyl radical with 3-5 C atoms, a cycloalkoxy radical with 4-6 C atoms, a cycloalkyl radical with 4-8 C atoms or an alkoxy alkoxy radical with a total of 3-5 C atoms. The invention also relates to a method for producing said compunds in addition to novel untermediate products and to a method for the production thereof.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: September 11, 2001
    Assignee: Dr. Willmar Schwabe GmbH & Co.
    Inventors: Shyam Sunder Chatterjee, Hermann Hauer
  • Patent number: 5925355
    Abstract: The preparation of a total extract of leaves and flowers of appropriate Crataegus species is described as well as three new fractions of said total extract and their use as pharmaceutical compositions for preventing sudden death due the cardiac arrest and reperfusion-caused cardiovascular lesions and other reperfusion-caused life-threatening pathological conditions.
    Type: Grant
    Filed: January 29, 1996
    Date of Patent: July 20, 1999
    Assignee: Willmar Schwabe GmbH & Co.
    Inventors: Shyam Sunder Chatterjee, Hermann Ernst Jaggy
  • Patent number: 5529995
    Abstract: The present invention relates to novel aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE.
    Type: Grant
    Filed: March 1, 1995
    Date of Patent: June 25, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Gary A. Flynn, Robert J. Cregge, Thomas L. Fevig, Shyam Sunder, Patrick W. Shum
  • Patent number: 5488048
    Abstract: The present invention relates to novel aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE.
    Type: Grant
    Filed: March 1, 1995
    Date of Patent: January 30, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Gary A. Flynn, Robert J. Cregge, Thomas L. Fevig, Shyam Sunder, Patrick W. Shum
  • Patent number: 5424425
    Abstract: The present invention relates to novel aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: June 13, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Gary A. Flynn, Robert J. Cregge, Thomas L. Fevig, Shyam Sunder, Patrick W. Shum
  • Patent number: 5011835
    Abstract: This invention is directed to a group of compounds which are acyl derivatives of amino substituted triazolopyridazines. They are prepared by the reaction of an aminotriazolopyridazine or an aminotriazolophthalazine with an appropriate acid chloride. These compounds possess bronchodilating and antiallergenic activity.
    Type: Grant
    Filed: February 7, 1990
    Date of Patent: April 30, 1991
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4871732
    Abstract: The present invention is directed to a group of compounds which are imidazo[2,1-b]quinazolin-5(3H)-ones, related tricyclic compounds, and pharmaceutically acceptable salts thereof. These compounds are useful as bronchodilators. These compounds are prepared by the reaction of an appropriate hydrazine with an appropriate 1-substituted-2-methyl-2-imidazoline or chemically equivalent compound.
    Type: Grant
    Filed: September 22, 1988
    Date of Patent: October 3, 1989
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4761474
    Abstract: 3-(1H-Tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones useful as antiallergic agents are described herein. The compounds are prepared by cyclization of an appropriate substituted amidine using an alkali metal base. The reaction is carried out in an appropriate inert solvent.
    Type: Grant
    Filed: February 25, 1986
    Date of Patent: August 2, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder, Anna P. Vinogradoff
  • Patent number: 4567193
    Abstract: 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and its pharmaceutically acceptable salts are useful as antiallergic agents. The compounds are prepared by the reaction of 2-amino-N-(1H-tetrazol-5-yl)benzamide with formic acetic anhydride.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: January 28, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4526979
    Abstract: Alkoxycarbonyl and oxalyl derivatives of amino-N-(1H-tetrazol-5-yl)benzamides are described herein. The compounds involved are useful as antiallergic agents. These compounds can be prepared by the reaction of an amino-N-(1H-tetrazol-5-yl)benzamide with an appropriate acid chloride.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: July 2, 1985
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4526890
    Abstract: 3,6,7,8-Substituted-s-triazolo-pyridazine compounds such as 7,8-dimethyl-6-morpholino-3-methyl-s-triazolo[4,3-b]pyridazine or 7,8-dimethyl-6-(1-pyrrolidinyl)-3-(isopropyl)-s-triazolo-[4,3-b]pyridazine are prepared by the reaction of a carboxylic acid with a substituted 3-hydrazino-6-halo-pyridazine followed by the reaction of the resulting 6-halotriazolopyridazine with a corresponding base. The compounds have pharmacological activity as bronchodilators.
    Type: Grant
    Filed: April 7, 1981
    Date of Patent: July 2, 1985
    Assignee: The Dow Chemical Company
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4485106
    Abstract: Substituted tetrahydrotetrazolo[5,1-a]phthalazine compounds such as 6-methylamino-7,8,9,10-tetrahydrotetrazolo[5,1-a]phthalazine are prepared by reacting a 6-halo-7,8,9,10-tetrahydrotetrazolo[5,1-a]phthalazine with an appropriate amine. The compounds are useful as bronchodilators.
    Type: Grant
    Filed: July 12, 1982
    Date of Patent: November 27, 1984
    Assignee: The Dow Chemical Company
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4419357
    Abstract: 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinones useful as antiallergic agents are described herein. The compounds are prepared by the reaction of an appropriate 2-amino-N-(1H-tetrazol-5-yl)benzamide with an appropriate ortho ester.
    Type: Grant
    Filed: January 18, 1982
    Date of Patent: December 6, 1983
    Assignee: The Dow Chemical Company
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4254125
    Abstract: A series of 2-chloro-3-phenoxypyrazines and 2-chloro-6-phenoxypyrazines exhibiting antiviral activity are disclosed. Methods of using the disclosed compounds as antiviral agents are also described as well as pharmaceutically-acceptable compositions.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: March 3, 1981
    Assignee: The Dow Chemical Company
    Inventors: Shyam Sunder, John K. Daniel, Norton P. Peet
  • Patent number: 4107436
    Abstract: Novel N-(2-hydroxyethyl)cycloalkylaminocarboxamides are described. The compounds are pharmacodynamically active and serve as intermediates for the preparation of corresponding 2-amino-2-oxazolines which are active pharmacodynamically.
    Type: Grant
    Filed: May 27, 1977
    Date of Patent: August 15, 1978
    Assignee: The Dow Chemical Company
    Inventors: Shyam Sunder, Norton P. Peet
  • Patent number: 4064348
    Abstract: Novel 2-cycloalkylamino-2-oxazolines and their salts are described which are biologically active. Member compounds exhibit useful activity as CNS-depressants, CNS-stimulants, platelet aggregation inhibitors, fungicides, and herbicides.
    Type: Grant
    Filed: November 10, 1976
    Date of Patent: December 20, 1977
    Assignee: The Dow Chemical Company
    Inventors: Norton P. Peet, Shyam Sunder
  • Patent number: 4052385
    Abstract: Novel N-(2-hydroxyethyl)heteroiminocarboxamides are described. The compounds are pharmacodynamically active and serve as intermediates for the preparation of corresponding 2-amino-2-oxazolines which are active pharmacodynamically.
    Type: Grant
    Filed: October 21, 1975
    Date of Patent: October 4, 1977
    Assignee: The Dow Chemical Company
    Inventors: Norton P. Peet, Shyam Sunder